McMaster

Why we need to reuse waste energy to achieve net-zero heating systems

Retrieved on: 
Monday, July 31, 2023

As we move toward a cleaner energy future, there is a growing push to electrify everything, from cars to home heating.

Key Points: 
  • As we move toward a cleaner energy future, there is a growing push to electrify everything, from cars to home heating.
  • While that sounds ideal, it is also much more than a matter of simply plugging in.

The importance of heating

    • To compare the overall energy required for heating and cooling buildings we look at heating degree days (HDD) versus cooling degree days (CDD).
    • In Toronto, for example, heating degree days outnumber cooling degree days about 7-1.

Utilize everything

    • By storing the heat generated from all sources, including waste heat, and drawing from it through the coldest months of the year, our research shows we can use discarded waste heat.
    • A huge amount of heat generated today is simply dissipated into our surroundings and wasted, and when it’s cold outside, we use new energy to make fresh heat.
    • There is already technology that can harvest and store such heat for months in underground thermal batteries until it is needed.

Integrated heat harvesting systems

    • McMaster leads a wider research co-operative demonstration project called Integrated Community Energy and Harvesting, or ICE-Harvest, with 30 municipalities and 19 industrial partners taking part.
    • In a new paper in the journal Applied Energy, we show how such localized systems use the same energy twice.

Heat batteries already exist

    • Think of it this way: the Canadian chain Pizza Pizza is piloting a system that uses heat recovered from its ovens to heat its own hot water.
    • In the same way an arena can sell its heat to a retirement home across the street; a grocery store to a neighbouring school, and so on.
    • Here in the northern hemisphere, heat is a valuable resource that’s already there waiting to be tapped, and we can no longer afford to waste it.

Government of Canada supporting Ontario universities with funding to reduce pollution to achieve environmental success

Retrieved on: 
Thursday, July 13, 2023

This funding will enable eligible facilities to achieve greater energy efficiency, adopt sustainable solutions, and reduce their emissions to support the transition to a low-carbon world.

Key Points: 
  • This funding will enable eligible facilities to achieve greater energy efficiency, adopt sustainable solutions, and reduce their emissions to support the transition to a low-carbon world.
  • McMaster University will receive $2,087,600 to reduce its natural gas usage for campus heating through the installation of electric boilers.
  • By investing pollution pricing proceeds in these forward-thinking institutions, the Government of Canada is supporting their efforts to transition to lower-cost, renewable energy sources.
  • The Government of Canada has committed to return proceeds collected from the OBPS to the jurisdictions of origin.

Cubic and McMaster Partnership Recognized in 7th Edition of the UITP Awards

Retrieved on: 
Monday, June 5, 2023

Cubic Transportation Systems (CTS), part of Cubic Corporation , and McMaster University today announced that Dr. Hanna Haponenko, postdoc at McMaster Automotive Resource Centre (MARC) , has been recognized with the UITP Young Researcher Award.

Key Points: 
  • Cubic Transportation Systems (CTS), part of Cubic Corporation , and McMaster University today announced that Dr. Hanna Haponenko, postdoc at McMaster Automotive Resource Centre (MARC) , has been recognized with the UITP Young Researcher Award.
  • The honor celebrates her work and contributions towards Mobility Cube — a collaborative program between Cubic and McMaster University in Hamilton, Ontario, Canada, focusing on Artificial Intelligence and Smart Mobility.
  • The award was announced at the UITP Global Public Transport Summit held June 4-7, 2023 in Barcelona.
  • Her dedication to advancing accessibility in transportation has earned her recognition, including the UITP Young Researcher Award.

Encora Appoints Ian McMaster as New Head of Partnerships and Ecosystem Alliances

Retrieved on: 
Wednesday, May 31, 2023

SCOTTSDALE, Ariz., May 31, 2023 /PRNewswire/ -- Encora, a global next-gen product engineering provider, today announced Ian McMaster has been appointed as its new Senior Vice President of Partnerships and Ecosystem Alliances. In this role, McMaster will be responsible for collaborating with cross-functional teams across Encora to create programs and solutions that drive business growth through alliances. McMaster joins Encora from Cognizant, where he served as Assistant Vice President, Global Head AI & Analytics Alliances.

Key Points: 
  • In this role, McMaster will be responsible for collaborating with cross-functional teams across Encora to create programs and solutions that drive business growth through alliances.
  • McMaster joins Encora from Cognizant, where he served as Assistant Vice President, Global Head AI & Analytics Alliances.
  • "Partnerships and alliances with industry leaders is a key enabler to our ability to better serve clients with the latest innovations in software development," said Anand, CEO, Encora.
  • "Ian has very impressive experience in securing these types of partnerships through his work at Microsoft, IBM and Cognizant.

Ceapro Inc. Presents Encouraging Results from Research Collaboration Study with McMaster University Evaluating PGX-Processed Yeast Beta Glucan for Interstitial Lung Diseases

Retrieved on: 
Tuesday, May 23, 2023

EDMONTON, Alberta, May 23, 2023 (GLOBE NEWSWIRE) --  Ceapro Inc.  (TSX-V: CZO; OTCQX: CRPOF) (“Ceapro” or the “Company”), a growth-stage biotechnology company focused on the development and commercialization of active ingredients for healthcare and cosmetic industries, today announced encouraging results from it’s completed pre-clinical CHRP study conducted with McMaster University evaluating PGX-processed yeast beta glucan (PGX-YBG) as a potential therapeutic option for individuals suffering from interstitial lung diseases (ILD).

Key Points: 
  • ILD damages the tissues between the small air sacs in the lungs (alveoli) and the blood vessels around them.
  • ILD represent a significant unmet medical need and is currently putting a major strain on healthcare systems around the globe.
  • Prior to the pandemic, Ceapro and accomplished researchers from McMaster University teamed up to develop a novel drug formulation for the potential treatment of IPF.
  • We are very encouraged by the results from this study showing that PGX-YBG has the ability of reprogramming macrophages to prevent fibrogenesis in mice.

Government of Canada supports project to improve awareness and reduce the risk of dementia in Canada

Retrieved on: 
Friday, May 26, 2023

Though dementia cannot be prevented and there is currently no cure, adopting healthy lifestyle behaviours can help reduce the risk.

Key Points: 
  • Though dementia cannot be prevented and there is currently no cure, adopting healthy lifestyle behaviours can help reduce the risk.
  • The Government of Canada is committed to supporting the more than 450,000 Canadians living with diagnosed dementia, their families, and caregivers.
  • We are also working with organizations across the country to increase awareness, reduce the risk of developing dementia, reduce stigma, and improve the quality of life of people living with dementia and their caregivers.
  • Since 2019, the Government of Canada has announced more than $300 million in funding that supports the national dementia strategy.

Fusion Pharmaceuticals Announces Opening of Radiopharmaceutical Manufacturing Facility to Produce Targeted Alpha Therapies for Cancer

Retrieved on: 
Tuesday, May 2, 2023

HAMILTON, ON, May 2, 2023 /PRNewswire/ -- Fusion Pharmaceuticals Inc. (Nasdaq: FUSN), a clinical-stage oncology company focused on developing next-generation radiopharmaceuticals as precision medicines, today announced the opening of its state-of-the-art radiopharmaceutical manufacturing facility. The 27,000 square foot good manufacturing practice (GMP) compliant facility, which is located adjacent to the Company's research and development labs, has clinical and commercial manufacturing scale capabilities designed to support the Company's growing pipeline of targeted alpha therapies (TATs).

Key Points: 
  • HAMILTON, ON, May 2, 2023 /PRNewswire/ -- Fusion Pharmaceuticals Inc. (Nasdaq: FUSN), a clinical-stage oncology company focused on developing next-generation radiopharmaceuticals as precision medicines, today announced the opening of its state-of-the-art radiopharmaceutical manufacturing facility.
  • The 27,000 square foot good manufacturing practice (GMP) compliant facility, which is located adjacent to the Company's research and development labs, has clinical and commercial manufacturing scale capabilities designed to support the Company's growing pipeline of targeted alpha therapies (TATs).
  • "Manufacturing and supply chain are critical components of radiopharmaceutical development and commercialization.
  • The new manufacturing facility, part of a 15-year lease agreement with Hamilton, Ontario-based McMaster University, was built by McMaster and equipped and validated by Fusion.

Applied Software's New Contest Seeks to Propel Students into Careers in Sustainable Construction

Retrieved on: 
Monday, May 1, 2023

ATLANTA, May 1, 2023 /PRNewswire/ -- Applied Software, GRAITEC Group, a leading systems integrator in the AEC, construction, and manufacturing industries, launched today a new scholarship award and essay contest to encourage high school students to explore careers in sustainable construction.

Key Points: 
  • ATLANTA, May 1, 2023 /PRNewswire/ -- Applied Software, GRAITEC Group, a leading systems integrator in the AEC, construction, and manufacturing industries, launched today a new scholarship award and essay contest to encourage high school students to explore careers in sustainable construction.
  • "This contest will appeal to not only students already interested in a related field, but we're also aiming at introducing opportunities in design, construction, sustainability, and building management to students who've never considered it."
  • Students submitting entries must simply be curious, define a challenge, and provide creative suggestions on how it might be solved.
  • More details including entry guidelines and terms and conditions can be found at the contest website: https://asti.com/high-school-sustainability-essay-contest/

Ceapro Announces Data from Research Collaboration with McMaster University to be Presented at the 2023 American Thoracic Society (ATS) International Conference

Retrieved on: 
Thursday, March 23, 2023

EDMONTON, Alberta, March 23, 2023 (GLOBE NEWSWIRE) -- Ceapro Inc. (TSX-V: CZO; OTCQX: CRPOF) (“Ceapro” or the “Company”), a growth-stage biotechnology company focused on the development and commercialization of active ingredients for healthcare and cosmetic industries, announced today that the abstract titled, “Reprogramming Rogue Macrophages: Yeast Beta-Glucan Microparticles as a Macrophage Modulator for Lung Fibrosis,” has been accepted for a presentation at the American Thoracic Society (ATS) International Conference to be held at the Walter E. Washington Convention Center in Washington, DC between May 19-24, 2023.

Key Points: 
  • EDMONTON, Alberta, March 23, 2023 (GLOBE NEWSWIRE) -- Ceapro Inc. (TSX-V: CZO; OTCQX: CRPOF) (“Ceapro” or the “Company”), a growth-stage biotechnology company focused on the development and commercialization of active ingredients for healthcare and cosmetic industries, announced today that the abstract titled, “Reprogramming Rogue Macrophages: Yeast Beta-Glucan Microparticles as a Macrophage Modulator for Lung Fibrosis,” has been accepted for a presentation at the American Thoracic Society (ATS) International Conference to be held at the Walter E. Washington Convention Center in Washington, DC between May 19-24, 2023.
  • The data to be presented by Mrs. Safaa Naiel, Ph.D. candidate, springs from the expanded research collaboration between Ceapro and McMaster researchers, Dr. Kjetil Ask, Dr. Todd Hoare and Dr. Martin Kolb, which is studying the anti-fibrotic properties of Ceapro’s PGX-Processed yeast beta glucan in experimental models of lung fibrosis and its potential as an inhalable immuno-therapeutic/-prophylactic in lung fibrotic diseases.
  • For more information about the conference, please visit the event website here .

Government of Canada invests new funding for post COVID-19 condition, in line with recommendations from the Chief Science Advisor's report

Retrieved on: 
Thursday, March 9, 2023

The Government of Canada is reviewing the Task Force's recommendations, which will be critical in informing future actions in responding to PCC.

Key Points: 
  • The Government of Canada is reviewing the Task Force's recommendations, which will be critical in informing future actions in responding to PCC.
  • The Long COVID Web research network is a pivotal step on the path to clearly defining and managing post COVID-19 condition in Canada.
  • "Canada's science community is well positioned to provide the government with the evidence and the expertise needed to address post COVID-19 condition.
  • The Government of Canada is reviewing Dr. Nemer's Task Force recommendations, which will be critical in informing future action in responding to PCC.